Christine A. Pellizzari

This profile gathers the share dealings of Christine A. Pellizzari across 4 companies, led by INSMED Inc, Science 37 Holdings, Inc. and Dendrite International Inc. Over a trading history stretching from 1 May 2006 to 31 July 2026, the count stands at 69 filings.

The open-market side counts 5 purchases for €381k alongside 19 sales for €6.7M. Taken together, the sales exceed the purchases by €6.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 18 share grants and 23 option exercises.

The median purchase comes to €100k. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 4 August 2026: a share grant of €9,572, in Imunon, Inc. The most recent open-market purchase was published on 17 November 2022, 1,437 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.